Clinical trial

Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in…

NCT00383734 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed

Key facts

NCT number NCT00383734
Title Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE
Official title Randomized, Comparative, Multicenter, Patient-blinded Trial of the Safety and Efficacy of Intradermal Injections of Polylactic Acid (Newfill TM) Versus Polyacrylamid Gel (Eutrophill) in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE
Lead sponsor French National Agency for Research on AIDS and Viral Hepatitis, Other
Collaborators Procitech Sanofi Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions HIV-Associated Lipodystrophy Syndrome
Intervention type Device
Interventions Newfill, Eutrophill
Enrollment 148
Start date Dec 1, 2006
Primary completion Sep 1, 2008
Completion Sep 1, 2010
First posted Oct 3, 2006
Last update posted Dec 22, 2011
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies